FDA Approves LifeVest Wearable Defibrillator for Children

Share this content:
FDA Approves LifeVest Wearable Defibrillator for Children
FDA Approves LifeVest Wearable Defibrillator for Children

THURSDAY, Dec. 17, 2015 (HealthDay News) -- The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

The wearable model weighs less than 2 pounds. It consists of an electrode belt and garment that surround the patient's chest, and a monitor that's worn around the waist. Users must weigh at least 41 pounds and have a chest size of 26 inches or greater, the size of an average 8-year-old, the FDA said.

The wearable device was first approved for adults in 2001, and later models were approved thereafter. The approval for children followed clinical studies of 248 people aged 3 to 17. No additional safety concerns were identified. Four patients who experienced sudden cardiac arrest received a shock that successfully restarted the heart.

"The pediatric medical community is often forced to use adult devices off-label without appropriate labeling or instructions for use in pediatric patients," Vasum Peiris, M.D., M.P.H., chief medical officer of pediatrics and special populations in the FDA's Center for Devices and Radiological Health, said in a statement. "Doctors now have important information that may help them safely prescribe this life-saving device to young patients."

The device is produced by Pittsburgh-based ZOLL Manufacturing.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »